BackAlbany Molecular Research Overview

Albany Molecular Research Total Assets

Albany Molecular Research's total assets is $1.2B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.24B
54.04% YoYΔ $435.87M vs prior year quarter

Peer average

Loading

Albany Molecular Research Total Assets History

Loading

Albany Molecular Research vs. peers: Total Assets Comparison

Loading

Albany Molecular Research Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Albany Molecular Research (AMRI) FAQ

As of the most recent data (June 2017), AMRI shows a total assets of $1.2B. That compares with $810M in the prior-year period — up 54.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMRI's total assets is now $1.2B (was $810M) — a 54.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Albany Molecular Research is outperforming or lagging.

Tracking AMRI's total assets over time shows whether Albany Molecular Research is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2B That compares with $810M in the prior-year period — up 54.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Albany Molecular Research's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $1.2B) with ownership activity and broader fundamentals.